Yu‐Ling Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu‐Ling Wu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Chaobin Pan
Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
1 shared publication - Dong-Xiao Tang
Department of Stomatology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
1 shared publication Hong‐Yu Li
Department of Oral & Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China
1 shared publicationJiu‐Yang Jiao
Department of Oral & Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China
1 shared publicationLing‐Jian Yan
Department of Oral & Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China
1 shared publicationQuan Wan
Department of Oral & Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 26 April 2017
- Published by Wiley in Cancer Science
- Vol. 108 (5) , 897-909
Mesenchymal stem cell‐derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells
Recent studies have demonstrated that mesenchymal stem cells (MSC) exhibit a tropism to tumors and form the tumor stroma. In addition, we found that MSC can secrete different types of factors. However, the involvement of MSC‐derived factors in human tongue squamous cell carcinoma (TSCC) growth has not been clearly addressed. The CCN family includes multifunctional signaling molecules that affect the initiation and development events of various tumors. In our study, we report that CCN2/connective tissue growth factor (CTGF) was the most highly induced among the CCN family members in MSC that were co‐cultured with TSCC cells. To evaluate the relationship between CCN2 and TSCC growth, we downregulated MSC‐derived CCN2 expression with shRNA targeting CCN2 and found that MSC‐secreted CCN2 promotes TSCC cell proliferation, migration and invasion. We also confirmed that MSC‐derived CCN2 partially accelerated tumor growth in vitro. Taken together, these results suggest that MSC‐derived CCN2 contributes to the promotion of proliferation, migration and invasion of TSCC cells and may be a possible therapy target in the future.
- 26 April 2017
- Published by Wiley in Cancer Science
- Vol. 108 (5) , 897-909
Open AccessMesenchymal stem cell‐derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells
Recent studies have demonstrated that mesenchymal stem cells (MSC) exhibit a tropism to tumors and form the tumor stroma. In addition, we found that MSC can secrete different types of factors. However, the involvement of MSC‐derived factors in human tongue squamous cell carcinoma (TSCC) growth has not been clearly addressed. The CCN family includes multifunctional signaling molecules that affect the initiation and development events of various tumors. In our study, we report that CCN2/connective tissue growth factor (CTGF) was the most highly induced among the CCN family members in MSC that were co‐cultured with TSCC cells. To evaluate the relationship between CCN2 and TSCC growth, we downregulated MSC‐derived CCN2 expression with shRNA targeting CCN2 and found that MSC‐secreted CCN2 promotes TSCC cell proliferation, migration and invasion. We also confirmed that MSC‐derived CCN2 partially accelerated tumor growth in vitro. Taken together, these results suggest that MSC‐derived CCN2 contributes to the promotion of proliferation, migration and invasion of TSCC cells and may be a possible therapy target in the future.